FOPEBI
LIVE

Serial Number

97514013

Owner

Clementia Pharmaceuticals Inc.

Attorney

Makiko Coffland

Filing Date

Jul 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

FOPEBI Trademark

Serial Number: 97514013

FOPEBI is a trademark filed by Clementia Pharmaceuticals Inc. on July 21, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Clementia Pharmaceuticals Inc.

1155 Rue Metcalfe, Suite 1500
Montreal, Quebec H3B2V6 , CA

Entity Type: 03

Trademark Details

Filing Date

July 21, 2022

Registration Date

Not Registered

Published for Opposition

September 26, 2023

Goods & Services

Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutinin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component of the toxin haemagglutinin complex for skin care and the treatment of neurological disorders

Filing History

SOU TEAS EXTENSION RECEIVED
Feb 24, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 23, 2025 EXRA
SOU EXTENSION 4 GRANTED
Aug 22, 2025 EX4G
SOU EXTENSION 4 FILED
Aug 22, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 22, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2025 EXRA
SOU EXTENSION 3 GRANTED
Feb 28, 2025 EX3G
SOU EXTENSION 3 FILED
Feb 27, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 27, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2024 EXRA
SOU EXTENSION 2 GRANTED
Aug 14, 2024 EX2G
SOU EXTENSION 2 FILED
Aug 14, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 1, 2024 EXRA
SOU EXTENSION 1 GRANTED
Feb 29, 2024 EX1G
SOU EXTENSION 1 FILED
Feb 29, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 29, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 19, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 19, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 19, 2023 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 21, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 16, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 16, 2023 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 16, 2023 GPRN
PRIORITY ACTION E-MAILED
Feb 16, 2023 GPRA
PRIORITY ACTION WRITTEN
Feb 16, 2023 CPRA
ASSIGNED TO EXAMINER
Feb 10, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2022 NWOS
NEW APPLICATION ENTERED
Jul 25, 2022 NWAP